Thermo Fisher Scientific Retained Earnings increased by 2.5% to $60.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.4%, from $54.45B to $60.63B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a 16.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals strong historical profitability and reinvestment, while a decrease may indicate losses or significant dividend payouts.
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
A key metric for all established companies; growth rates are compared against peers to gauge long-term success.
retained_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $32.08B | $33.88B | $35.43B | $37.53B | $39.07B | $40.45B | $41.91B | $43.06B | $44.29B | $45.87B | $47.36B | $48.54B | $49.94B | $51.42B | $53.10B | $54.45B | $55.90B | $57.35B | $59.16B | $60.63B |
| QoQ Change | — | +5.6% | +4.6% | +5.9% | +4.1% | +3.5% | +3.6% | +2.8% | +2.8% | +3.6% | +3.3% | +2.5% | +2.9% | +3.0% | +3.3% | +2.5% | +2.7% | +2.6% | +3.1% | +2.5% |
| YoY Change | — | — | — | — | +21.8% | +19.4% | +18.3% | +14.8% | +13.3% | +13.4% | +13.0% | +12.7% | +12.8% | +12.1% | +12.1% | +12.2% | +11.9% | +11.5% | +11.4% | +11.4% |